*Department of Pharmaceutical Sciences, Seoul National University;

†Research Institute of Pharmaceutical Sciences, Seoul National University;

‡Korea National Enterprise for Clinical Trials, National Center for Clinical Research Service, Seoul, Korea;

§BioInfra Co Ltd, Gyunggi Bio-center, Suwon; and

¶Department of Surgery and the Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.

Correspondence: Jangik I. Lee, PharmD, PhD, Clinical and Regulatory Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-Ro, Gwanak-Gu, Seoul 08826, Republic of Korea (e-mail: [email protected]) or Dong Jin Joo, MD, PhD, FACS, Department of Surgery, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul 03722, Republic of Korea (e-mail: [email protected]).

Supported by SoVarGen Co Ltd, the National Research Foundation of Korea (2018R1D1A1B07044329), and the fourth phase of the Brain Korea 21 Program in 2021.

The authors declare no conflict of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.drug-monitoring.com).